Skip to content
All articles

TUDCA Dosage: The Doses Used in Human Studies

Gloved hands fill rows of teal capsules in a capsule-filling tray; below a blurred band the words "TUDCA dosage: The doses used in human studies."
Table of contents
  1. What to know
  2. What Is the Typical TUDCA Dosage?
  3. What Doses Have Been Used in Human Studies?
  4. What Does "Per Kg" Dosing Mean?
  5. How Was TUDCA Taken in the Studies?
  6. Does a Higher Dose Cause More Side Effects?
  7. Is There an Upper Limit for TUDCA?
  8. TUDCA 250 mg vs 500 mg: What Is the Difference?
  9. How Much TUDCA for the Liver or Fatty Liver?
  10. Who Should Talk to a Doctor Before Taking TUDCA?
  11. Where Does TUDCA Fit After Gallbladder Removal?
  12. In Summary: TUDCA Dosage
  13. Frequently Asked Questions
  14. References

Studies that gave TUDCA as a fixed daily amount used 500 mg to 2 g a day, while others set the dose by body weight, and the Italian and Turkish medicine labels give 5 to 10 mg per kg a day, usually 250 to 750 mg, in divided doses after meals. The doses below are reported exactly as each study or label gave them.


What to know

  • Studies using a fixed daily amount gave 500 mg to 2 g; we found none of TUDCA alone above 2 g.
  • Digestive and liver studies mostly used 500 to 750 mg a day, within the labels' usual range.
  • Studies of metabolism, ulcerative colitis, ALS and multiple sclerosis gave higher amounts, 1,750 mg to 2 g daily.
  • The labels give it in divided doses after meals, and two say to lower the dose if diarrhea occurs.
  • The labels' doses are for medical use under a doctor's supervision.

Ask how much TUDCA to take and you will find numbers from 250 mg to several grams, often with no source, and sometimes borrowed from bodybuilding forums. Some pages convert study doses by body weight into personal recommendations, which the studies themselves didn't do.

This guide does something simpler. It sets out the doses that were actually used in studies of TUDCA in people and on its medicine labels, exactly as they were given, explains what "per kg" means, and is clear about what remains unknown. It doesn't recommend a dose.

What Is the Typical TUDCA Dosage?

Studies that gave TUDCA as a fixed daily amount used 500 mg to 2 g a day, and we found no study of TUDCA on its own above 2 g [1, 2]. The Italian and Turkish medicine labels give 5 to 10 mg per kg of body weight a day, usually 250 to 750 mg, in divided doses after meals [3, 4].

Those are two different kinds of number. The labels describe how TUDCA is used as a medicine, under a doctor's supervision, mainly for gallstone problems [3, 4]. The studies tested particular doses in particular conditions.

What Doses Have Been Used in Human Studies?

The doses below are shown as each study reported them. Some older studies, like the labels, set the dose by body weight, while most newer ones used a fixed daily amount.

Who was studied Daily dose How long
Adults after gallbladder removal 500 mg 3 months
People with chronic hepatitis C 500 or 750 mg 6 months
People with primary biliary cholangitis 500, 1,000 or 1,500 mg 6 months
People with primary biliary cholangitis 750 mg 24 weeks
Adults with obesity 1,750 mg 4 weeks
People with ulcerative colitis 1,750 to 2,000 mg 6 weeks
People with multiple sclerosis 2 g 16 weeks
People with ALS 2 g 54 weeks

The sources for each row are [5], [6], [7], [8], [9], [10], [2] and [1]. Our TUDCA safety review lists all 33 studies of TUDCA on its own with their doses.

What Does "Per Kg" Dosing Mean?

Some studies and the medicine labels give TUDCA as milligrams per kilogram of body weight, so the daily amount changes with a person's size. Measured against body weight, adult studies ranged from 3.5 to 20 mg per kg each day [11, 12], while a study in newborns used 30 mg per kg [13].

Dosing by weight means a heavier person takes more and a lighter person less. Early studies measured the effect on bile against the dose per kilogram: in one, in people with gallstones, cholesterol saturation in bile fell as the dose rose [11]. We don't convert those per-kg doses into amounts for individuals, because the studies weren't designed to set personal doses and supplements come in fixed amounts.

How Was TUDCA Taken in the Studies?

The labels give TUDCA in divided doses after meals [3, 4], and trials used one to three doses a day [14, 10]. One large ALS trial gave 1 g twice a day, 10 to 15 minutes after a meal [15], and a metabolism trial split the daily amount across breakfast, lunch and dinner [16]. Our guide to when to take TUDCA covers timing.

Does a Higher Dose Cause More Side Effects?

Two studies give some information on this. In an Italian registry of people with ALS, 5 side effects were recorded among the 20 people taking under 1,000 mg a day and 15 among the 66 taking 1,000 mg or more, which the authors described as no difference [17]. A study in primary biliary cholangitis that compared 500, 1,000 and 1,500 mg a day reported diarrhea as the only side effect, without saying at which doses [7].

The Italian Tudcabil and Turkish Taurolite labels say to lower the dose if diarrhea occurs and to stop if it continues [3, 4]. One ALS trial's protocol let participants drop to 1 g a day for up to two weeks after diarrhea, to adjust [18]. Our guide to TUDCA side effects covers what the trials recorded.

Recommended to you

Post-Gallbladder Bile & Liver Support

  • Restore Bile Fluidity
  • Improve Fat Breakdown
  • Support Liver Cells

Is There an Upper Limit for TUDCA?

We found no official upper limit for TUDCA. In the US, the FDA does not approve dietary supplements before they are sold [19], and we found no FDA limit for TUDCA; Health Canada's ingredient database lists TUDCA but gives no dose or monograph for it [20]. The highest amount of TUDCA alone tested in people is 2 g a day [1]. The Italian and Turkish labels give 5 to 10 mg per kg a day, usually 250 to 750 mg, and leave adjustments to the doctor, without stating a maximum [3, 4].

The Italian label's overdose section names diarrhea, and says other effects are unlikely because the body absorbs a smaller share of TUDCA at higher doses [3].

TUDCA 250 mg vs 500 mg: What Is the Difference?

The difference is the amount in each capsule or serving. TUDCA supplements in the US most often list 250 mg or 500 mg per serving [21], so check how many capsules make a serving before comparing products. The studies above report daily totals, not capsule strengths.

Whatever product you choose, follow its directions and don't exceed the daily amount on the label.

How Much TUDCA for the Liver or Fatty Liver?

In liver studies, people with chronic hepatitis C or primary biliary cholangitis took 500 to 1,500 mg a day [6, 7]. Those doses were used to study liver disease, not to support a healthy liver. For fatty liver, TUDCA hasn't been tested as a treatment, and in a four-week trial at 1,750 mg a day, liver fat did not change [9]. Our guide to TUDCA for liver health covers that research.

Who Should Talk to a Doctor Before Taking TUDCA?

The medicine labels rule TUDCA out in pregnancy, with an active stomach or duodenal ulcer and with some gallbladder and bile duct problems, and the Italian label adds breastfeeding [3, 4]. They also list medicines to space or avoid. If any of these apply to you, or you take prescription medicines, talk to your doctor or pharmacist about whether and how to take it. Our guide to who should not take TUDCA covers each caution.

Where Does TUDCA Fit After Gallbladder Removal?

Dr.Primal's TUDCA is made for life after gallbladder removal and taken with meals, to support healthy bile flow and fat digestion. Its directions are two capsules (500 mg), taken with food.

In Summary: TUDCA Dosage

Studies using a fixed daily amount gave TUDCA at 500 mg to 2 g a day, with digestive and liver studies mostly at 500 to 750 mg and trials in other conditions at 1,750 mg to 2 g. The medicine labels give 5 to 10 mg per kg a day, usually 250 to 750 mg, in divided doses after meals. None of these is a personal recommendation, and the label on your product is the dose to follow.

If you are working out whether bile is behind your symptoms after meals, our digestion quiz is a quick way to put your symptoms and habits in order.

Frequently Asked Questions

How much TUDCA per day?

Studies using a fixed daily amount gave 500 mg to 2 g a day [5, 1], and the medicine labels give 5 to 10 mg per kg a day, usually 250 to 750 mg, in divided doses after meals [3]. For a supplement, the product's own directions set the daily amount.

Is 1,000 mg of TUDCA too much?

Trials in people with ALS and multiple sclerosis used 2 g a day [1, 2], and in an Italian registry of people with ALS, side effects were recorded about as often above 1,000 mg a day as below it [17]. Follow the directions on the product you take.

Should TUDCA be dosed by weight?

The medicine labels and some older studies dosed it by weight, at 5 to 10 mg per kg a day on the labels [3]. Supplements give a fixed amount per serving instead, which is why their directions name a number of capsules.

Can I take TUDCA every day?

The labels give a daily dose, and trials gave it daily for months, in some cases for about a year, with side effects about as common as on placebo [3, 1]. Our guide to how long to take TUDCA covers long-term use.

References

  1. Elia AE, Lalli S, Monsurrò MR, et al. Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis. Eur J Neurol. 2016;23(1):45-52. PubMed
  2. Ladakis DC, Harrison KL, Smith MD, et al. Bile acid metabolites predict multiple sclerosis progression and supplementation is safe in progressive disease. Med. 2025;6(3):100522. PubMed
  3. Agenzia Italiana del Farmaco. Tudcabil 250 mg capsule rigide: riassunto delle caratteristiche del prodotto (summary of product characteristics). Bruschettini S.r.l.; made available by AIFA January 31, 2021. AIFA
  4. Türkiye İlaç ve Tıbbi Cihaz Kurumu (TITCK). Taurolite 250 mg kapsül: kısa ürün bilgisi (summary of product characteristics). Bio-Gen İlaç. Accessed October 17, 2026. TITCK
  5. Croce E, Golia M, Trignano M, et al. [Rationale for the use of bile salts after cholecystectomy: results of a controlled clinical study using tauroursodeoxycholic acid (TUDCA)]. Ann Ital Chir. 1993;64(5):533-537. PubMed
  6. Crosignani A, Budillon G, Cimino L, et al. Tauroursodeoxycholic acid for the treatment of HCV-related chronic hepatitis: a multicenter placebo-controlled study. Hepatogastroenterology. 1998;45(23):1624-1629. PubMed
  7. Crosignani A, Battezzati PM, Setchell KD, et al. Tauroursodeoxycholic acid for treatment of primary biliary cirrhosis. A dose-response study. Dig Dis Sci. 1996;41(4):809-815. PubMed
  8. Ma H, Zeng M, Han Y, et al. A multicenter, randomized, double-blind trial comparing the efficacy and safety of TUDCA and UDCA in Chinese patients with primary biliary cholangitis. Medicine (Baltimore). 2016;95(47):e5391. PubMed
  9. Kars M, Yang L, Gregor MF, et al. Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes. 2010;59(8):1899-1905. PubMed
  10. Lamm V, Huang K, Deng R, et al. Tauroursodeoxycholic Acid (TUDCA) Reduces ER Stress and Lessens Disease Activity in Ulcerative Colitis. medRxiv. 2025. Preprint posted April 4, 2025. doi:10.1101/2025.04.02.25322684. PubMed
  11. Muraca M, Vilei MT, Cianci V, Liu XT, Garotta F. Effect of tauroursodeoxycholic acid on biliary lipid composition. A dose-response study. Int J Clin Pharmacol Ther. 1995;33(7):391-393. PubMed
  12. Hardison WG, Grundy SM. Effect of ursodeoxycholate and its taurine conjugate on bile acid synthesis and cholesterol absorption. Gastroenterology. 1984;87(1):130-135. PubMed
  13. Heubi JE, Wiechmann DA, Creutzinger V, et al. Tauroursodeoxycholic acid (TUDCA) in the prevention of total parenteral nutrition-associated liver disease. J Pediatr. 2002;141(2):237-242. PubMed
  14. ClinicalTrials.gov. Tauroursodeoxycholic acid for protease-inhibitor associated insulin resistance. NCT01877551. Washington University School of Medicine. Results posted January 27, 2020. Accessed October 17, 2026. ClinicalTrials.gov
  15. ClinicalTrials.gov. Safety and efficacy of tauroursodeoxycholic (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS). NCT03800524. Humanitas Mirasole SpA. Accessed October 17, 2026. ClinicalTrials.gov
  16. ClinicalTrials.gov. Effect of endoplasmic reticulum stress on metabolic function. NCT00771901. Washington University School of Medicine. Accessed October 17, 2026. ClinicalTrials.gov
  17. Zucchi E, Musazzi UM, Fedele G, et al. Effect of tauroursodeoxycholic acid on survival and safety in amyotrophic lateral sclerosis: a retrospective population-based cohort study. EClinicalMedicine. 2023;65:102256. PubMed
  18. Albanese A, Ludolph AC, McDermott CJ, et al. Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol. Front Neurol. 2022;13:1009113. PubMed
  19. US Food and Drug Administration. Questions and answers on dietary supplements. Content current as of August 27, 2026. FDA
  20. Health Canada. Natural Health Products Ingredients Database: chemical substance, tauroursodeoxycholic acid (record 4785). Date modified March 1, 2019. Accessed October 21, 2026. Health Canada
  21. National Institutes of Health, Office of Dietary Supplements. Dietary Supplement Label Database: labels listing tauroursodeoxycholic acid (TUDCA). Searched October 21, 2026. NIH DSLD

This article is for general education and is not a substitute for advice from your doctor. TUDCA is sold as a dietary supplement. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Read next

Welcome offer